Latest News and Press Releases

AVITA Medical data at SRBC 2025 confirms RECELL® as standard of care, improving healing, reducing hospital stays, and lowering treatment costs

AVITA Medical to announce Q3 2025 financial results on Nov 6; webcast to discuss performance and business highlights

MSAC backs AVITA Medical’s RECELL® for burns, recognizing its safety, healing benefits, donor site sparing, and reduced hospital stays.

Board Chairman Cary Vance appointed Interim CEOBoard member Jan Stern Reed appointed Lead Independent DirectorThird quarter 2025 preliminary revenue expected to be approximately $17 million VALENCIA,...

CMS grants NTAP for RECELL, adding up to $4,875 reimbursement for non-burn acute wounds, easing hospital costs and expanding patient access.

AVITA Medical has received the CE Mark for RECELL GO. This mark enables AVITA to begin commercializing RECELL GO across Europe.

Real-world data shows AVITA's RECELL System reduces hospital stays for burn patients by 36%, saving over $42,000 per patient vs. traditional grafts

AVITA Medical will participate in three investor conferences in September 2025 in New York, with CEO Jim Corbett and CFO David O’Toole

AVITA Medical Successfully Completes Australian Equity Raise

AVITA Medical to Host Investor Webinar Briefing